Cisplatin injection 10 mg/ 50 mg

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes certrorelix acetate injection (0.25 / vial). It belongs to gynaecology finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrizine di hcl. It belongs toantiallergic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrorelix acetate. It belongs to infertility apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetuximab. It belongs to monoclonal antibodies apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate. It belongs to antialzheimer apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate 400 mg soft caps & 250 mg/ml injection. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citalopram hydrobromide. It belongs to antideperessant apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline 500 mg + peracetam 400/800 mg. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline injection 250 mg/ml. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline sodium. It belongs to antialzheimer apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline tablets 200 mg/ 500 mg/ 750 mg/ 1000 mg. It belongs to central nervous system finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]. It belongs to ranolazine intermediates products category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.